Cancer cells that have broken away from a primary tumor can lurk in the body for years in a dormant state, evading immune ...

In a TNBC animal model with limited responsiveness to chemotherapy, Telomir-1 demonstrated statistically significant activity ...

KAIST researchers have developed a way to reprogram immune cells already inside tumors into cancer-killing machines. A drug ...

Noetik CEO and co-founder Ron Alfa, M.D., Ph.D., said the licensing of human foundation models is “a new paradigm in biotech.” With the GSK deal validating the paradigm, in Alfa’s view, Noetik ...

An international project to develop a large, globally accessible bank of new cancer cell culture models for the research community launched today. The National Cancer Institute (NCI), part of the ...

The study, published in British scientific journal Nature, suggests that the disease may begin in basal stem cells — ...

Stanford University-led researchers report that tumor cells hijack mitochondria from immune cells, reducing anti-tumor immune ...

Of all the types of breast cancer, triple negative breast cancer (TNBC) is the most aggressive and lacks specific therapies.

Researchers have identified a previously unknown inflammatory mechanism that may drive the aggressiveness and relapse of ...

New Memorial Sloan Kettering Cancer Center research reveals how dormant metastatic cancer cells protect themselves from the ...